When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)

Autor: Susan Brown, Cornelia Ploeger, Boliang Guo, Juliana J. Petersen, Amy C. Beckenstrom, Michael Browning, Gerard R. Dawson, Jürgen Deckert, Rebecca Dias, Colin T. Dourish, Philip Gorwood, Jonathan Kingslake, Andreas Menke, Victor Perez Sola, Andreas Reif, Henricus Ruhe, Judit Simon, Michael Stäblein, Anneke van Schaik, Dick J. Veltman, Richard Morriss

Publikováno v: Comprehensive Psychiatry, Vol 132, Iss , Pp 152467- (2024)

Background: A RCT of a novel intervention to detect antidepressant medication response (the PReDicT Test) took place in five European countries, accompanied by a nested study of its acceptability and implementation presented here. The RCT results ind

Externí odkaz: https://doaj.org/article/11a27d2f3afd4498ad09e6b90ac16f39

Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

Autor: Jan Scott, Diego Hidalgo-Mazzei, Rebecca Strawbridge, Allan Young, Matthieu Resche-Rigon, Bruno Etain, Ole A. Andreassen, Michael Bauer, Djamila Bennabi, Andrew M. Blamire, Fawzi Boumezbeur, Paolo Brambilla, Nadia Cattane, Annamaria Cattaneo, Marie Chupin, Klara Coello, Yann Cointepas, Francesc Colom, David A. Cousins, Caroline Dubertret, Edouard Duchesnay, Adele Ferro, Aitana Garcia-Estela, Jose Goikolea, Antoine Grigis, Emmanuel Haffen, Margrethe C. Høegh, Petter Jakobsen, Janos L. Kalman, Lars V. Kessing, Farah Klohn-Saghatolislam, Trine V. Lagerberg, Mikael Landén, Ute Lewitzka, Ashley Lutticke, Nicolas Mazer, Monica Mazzelli, Cristina Mora, Thorsten Muller, Estanislao Mur-Mila, Ketil Joachim Oedegaard, Leif Oltedal, Erik Pålsson, Dimitri Papadopoulos Orfanos, Sergi Papiol, Victor Perez-Sola, Andreas Reif, Philipp Ritter, Roberto Rossi, Thomas Schulze, Fanny Senner, Fiona E. Smith, Letizia Squarcina, Nils Eiel Steen, Pete E. Thelwall, Cristina Varo, Eduard Vieta, Maj Vinberg, Michele Wessa, Lars T. Westlye, Frank Bellivier

Publikováno v: International Journal of Bipolar Disorders, Vol 7, Iss 1, Pp 1-10 (2019)

Abstract Background Lithium is recommended as a first line treatment for bipolar disorders. However, only 30% of patients show an optimal outcome and variability in lithium response and tolerability is poorly understood. It remains difficult for clin

Externí odkaz: https://doaj.org/article/57ee4627676f46439dd606349ebeed81

Consenso de expertos sobre propuestas de información al paciente en tratamiento con sales de litio

Autor: Luis Gutiérrez-Rojas, José Manuel Montes, Anna Giménez Palomo, Ana González-Pinto, Consuelo de Dios Perrino, José Manuel Crespo, Vicent Balanzá-Martínez, Ángel Luis Montejo González, Antoni Benabarre Hernández, Victor Perez Sola

Publikováno v: Revista de Psiquiatría y Salud Mental. 14:27-39

Introduction: Lithium is one of the first therapeutic options for bipolar disorder, which is characterized by recurrent mood swings that strongly reduce quality of life. Our purpose was to achieve professional consensus criteria to define the content

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aeca92d3199503f92e89049a9071a2c1
https://doi.org/10.1016/j.rpsm.2019.11.001

The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial

Autor: Richard Morriss, Michael Stäblein, Matilde Elices, Victor Perez Sola, Michael Browning, Philip Gorwood, Boliang Guo, Elisabetta Scanferla, Catherine J. Harmer, Andreas Reif, Henricus G. Ruhé, Colin T. Dourish, Judit Simon, Gerard R Dawson, Anne G. Lever, Jürgen Deckert, Dick J. Veltman, Guy M. Goodwin, Rebecca Dias, Anneke van Schaik, Andreas Menke, Amy C. Bilderbeck, J Kingslake

Publikováno v: Neuropsychopharmacology
Neuropsychopharmacology, 2021, 46 (7), pp.1307-1314. ⟨10.1038/s41386-021-00981-z⟩
Neuropsychopharmacology, 46, 1307-14
Neuropsychopharmacology, Nature Publishing Group, 2021, 46 (7), pp.1307-1314. ⟨10.1038/s41386-021-00981-z⟩
Neuropsychopharmacology, 46(7), 1307-1314. Nature Publishing Group
Neuropsychopharmacology, 46, 7, pp. 1307-14
Browning, M, Bilderbeck, A C, Dias, R, Dourish, C T, Kingslake, J, Deckert, J, Goodwin, G M, Gorwood, P, Guo, B, Harmer, C J, Morriss, R, Reif, A, Ruhe, H G, van Schaik, A, Simon, J, Sola, V P, Veltman, D J, Elices, M, Lever, A G, Menke, A, Scanferla, E, Stäblein, M & Dawson, G R 2021, ' The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT) : an open-label, randomised controlled trial ', Neuropsychopharmacology, vol. 46, no. 7, pp. 1307-1314 . https://doi.org/10.1038/s41386-021-00981-z

Depressed patients often do not respond to the first antidepressant prescribed, resulting in sequential trials of different medications. Personalised medicine offers a means of reducing this delay; however, the clinical effectiveness of personalised

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4e3c402453136f641b9eb8aa58f392
https://www.hal.inserm.fr/inserm-03280352

A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

Autor: Sónia Quintão, José Luis Ayuso-Mateos, Ana González-Pinto, Georg Juckel, Adriana García Alocén, István Bitter, Roland Mergl, Victor Perez Sola, Ricardo Gusmão, Eduard Vieta, Csilla Bolyos, Koen Demyttenaere, Pilar Lopez-Garcia, Ulrich S. Zimmermann, Pascal Sienaert, Michael Bauer, Iñaki Zorrilla, Michael Kluge, Jens Dietzel, Christian Sander, Ulrich Hegerl, Marc-Andreas Edel

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)

Based on many clinical and preclinical findings the ‘vigilance regulation model of mania’ postulates that an unstable regulation of wakefulness is a pathogenetic factor in both mania and Attention Deficit Hyperactivity Disorder (ADHD) and induces

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184c0e7fe123ea7f0b64281c8e645a64